Next Article in Journal
Cytomegaloviruses in a Community of Wild Nonhuman Primates in Taï National Park, Côte D’Ivoire
Next Article in Special Issue
Sustained IFN-I Expression during Established Persistent Viral Infection: A “Bad Seed” for Protective Immunity
Previous Article in Journal
The Abrogation of Phosphorylation Plays a Relevant Role in the CCR5 Signalosome Formation with Natural Antibodies to CCR5
Previous Article in Special Issue
RNA Interference Therapies for an HIV-1 Functional Cure
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessReview
Viruses 2018, 10(1), 10; https://doi.org/10.3390/v10010010

Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings

1
McGill University AIDS Centre, Lady Davis Institute for Medical Research, Montreal, QC H3T 1E2, Canada
2
Département de Microbiologie et d’Immunologie et Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CHUM), Montreal, QC H2X 0A9, Canada
*
Author to whom correspondence should be addressed.
Received: 7 December 2017 / Revised: 22 December 2017 / Accepted: 24 December 2017 / Published: 28 December 2017
(This article belongs to the Special Issue Homage to Mark Wainberg)
Full-Text   |   PDF [1518 KB, uploaded 28 December 2017]   |  

Abstract

HIV continues to spread among vulnerable heterosexual (HET), Men-having-Sex with Men (MSM) and intravenous drug user (IDU) populations, influenced by a complex array of biological, behavioral and societal factors. Phylogenetics analyses of large sequence datasets from national drug resistance testing programs reveal the evolutionary interrelationships of viral strains implicated in the dynamic spread of HIV in different regional settings. Viral phylogenetics can be combined with demographic and behavioral information to gain insights on epidemiological processes shaping transmission networks at the population-level. Drug resistance testing programs also reveal emergent mutational pathways leading to resistance to the 23 antiretroviral drugs used in HIV-1 management in low-, middle- and high-income settings. This article describes how genotypic and phylogenetic information from Quebec and elsewhere provide critical information on HIV transmission and resistance, Cumulative findings can be used to optimize public health strategies to tackle the challenges of HIV in “real-world” settings. View Full-Text
Keywords: HIV-1/AIDS; phylogenetics; HIV drug resistance; genotyping; antiretroviral therapy; treatment-as-prevention HIV-1/AIDS; phylogenetics; HIV drug resistance; genotyping; antiretroviral therapy; treatment-as-prevention
Figures

Graphical abstract

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited (CC BY 4.0).
SciFeed

Share & Cite This Article

MDPI and ACS Style

Brenner, B.G.; Ibanescu, R.-I.; Hardy, I.; Roger, M. Genotypic and Phylogenetic Insights on Prevention of the Spread of HIV-1 and Drug Resistance in “Real-World” Settings. Viruses 2018, 10, 10.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Viruses EISSN 1999-4915 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top